Application of MALDI-TOF MS in clinical difficult blood group typing
10.13303/j.cjbt.issn.1004-549x.2022.09.010
- VernacularTitle:MALDI-TOF MS质谱技术在疑难血型标本鉴定中的应用
- Author:
Aijing LI
1
;
Minghao LI
1
;
Jiaxuan YANG
1
;
Qiong LU
1
;
Wei SHEN
1
;
Jiewei ZHENG
1
;
Sha JIN
1
;
Dong XIANG
1
;
Qixiu YANG
1
;
Ziyan ZHU
1
;
Luyi YE
1
Author Information
1. Shanghai Blood Center, Shanghai 200051, China
- Publication Type:Journal Article
- Keywords:
matrix-assisted laser desorption ionization-time of flight mass spectrometry;
blood group genotyping;
rare blood group;
complicated blood group samples
- From:
Chinese Journal of Blood Transfusion
2022;35(9):923-928
- CountryChina
- Language:Chinese
-
Abstract:
【Objective】 To explore the application of matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS) in the genotyping of difficult blood typing samples, and to provide evidence for clinical blood transfusion. 【Methods】 Three ambiguous blood group samples, submitted to Shanghai Blood Center by Shanghai regional hospitals, were studied, of which Sample1 included the proband and his parents. Serological methods were used to perform blood group typing, direct antibody test, unexpected antibody screening and identification test. Blood group genotyping was performed by using the MALDI-TOF MS detection systeme stablished in our laboratory. Sanger sequencing was used to confirm gene mutation sites, and serological or flow methods were used to verify specific samples′ phenotype. 【Results】 Serological results indicated the existence of antibodies against high frequency antigens in sample 1 (including proband and her mother), 2 and 3. The genotyping results of MALDI-TOF MS showed that the proband of sample 1 was Di(a+ b+ ), her father was Di(a-b+ ), her mother was Di(a+ b-), sample 2 was p, and sample 3 was Jr(a-). Sequencing results of three samples were consistent with mass spectrometry typing results. Serological results showed that sample 2 had a p phenotype. The flow cytometry results suggested that sample 3 had a Jr(a-) phenotype. 【Conclusion】 For the first time, we applied MALDI-TOF MS technology to blood type genotyping of ambiguous clinical samples in China. Compared with other genotyping methods such as PCR-SSP, MALDI-TOF MS has the advantages of rapid detection, high throughput and high specificity, which would contribute to identification of difficult blood typing samples in the future, as well as rare blood group screening.
